CardioNexus gets FDA ok for cardiac ultrasound system

CardioNexus, a joint venture between Panasonic and Houston-based Fairway Medical Technologies, has received the FDA's nod for an ultrasound system for the early detection of heart disease.

The company's CardioHealth Station uses a portable ultrasound system for non-invasive heart examinations. It can detect arterial plaque and measure the thickness of arterial walls, the Houston Business Journal notes.

Last October, Panasonic announced it had completed an investment in CardioNexus as part of a move to establish itself as a global leader in personalized preventive medicine. And the following month, Panasonic said it hoped to start CardioHealth system sales as soon as it received FDA approval.

- see the Houston Business Journal story

Suggested Articles

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.

Takeda teamed up with Enzyre to develop an at-home diagnostic device that will help people with hemophilia determine their own coagulation status.

Foundation Medicine received a diagnostic approval from the FDA for selecting HR+/HER2- breast cancer patients for treatment with Novartis' Piqray.